Loading company…
Hangzhou pharmaceutical R&D company focused on drug crystal and solid-state technology, with dermatology and nephrology products.
Soli Pharma, established in 2010 and based in Hangzhou, China, provides R&D, production and drug registration services to more than 800 customers worldwide. The company researches over 2,000 compound molecules, runs over 20,000 tests per year, and has developed more than 30 commercial and in-development drugs, including innovative, generic, US OTC and functional skin care products. Its products serve the dermatology and nephrology fields.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in